IRIS
PAPPALARDO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.048
EU - Europa 2.652
AS - Asia 1.675
AF - Africa 399
SA - Sud America 370
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 8
Totale 10.193
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.858
SG - Singapore 920
IT - Italia 804
CN - Cina 619
IE - Irlanda 595
UA - Ucraina 382
BR - Brasile 342
CI - Costa d'Avorio 309
DE - Germania 192
CA - Canada 175
RU - Federazione Russa 143
FI - Finlandia 130
FR - Francia 85
BE - Belgio 59
SN - Senegal 57
AT - Austria 54
GB - Regno Unito 48
NL - Olanda 38
VN - Vietnam 32
SE - Svezia 28
AU - Australia 27
CZ - Repubblica Ceca 24
NG - Nigeria 18
CH - Svizzera 14
NZ - Nuova Zelanda 14
UZ - Uzbekistan 13
GR - Grecia 12
ES - Italia 11
JP - Giappone 11
IQ - Iraq 10
PL - Polonia 9
TR - Turchia 9
AR - Argentina 8
EU - Europa 8
PK - Pakistan 8
PT - Portogallo 8
MX - Messico 7
BD - Bangladesh 6
IR - Iran 6
LB - Libano 6
VE - Venezuela 6
BG - Bulgaria 5
HK - Hong Kong 5
HU - Ungheria 5
KZ - Kazakistan 5
CO - Colombia 4
EC - Ecuador 4
IN - India 4
KG - Kirghizistan 4
TN - Tunisia 4
EG - Egitto 3
JM - Giamaica 3
NP - Nepal 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
CR - Costa Rica 2
GA - Gabon 2
JO - Giordania 2
KE - Kenya 2
KR - Corea 2
KW - Kuwait 2
NO - Norvegia 2
PE - Perù 2
ZA - Sudafrica 2
AO - Angola 1
BY - Bielorussia 1
CL - Cile 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
ID - Indonesia 1
IL - Israele 1
LV - Lettonia 1
ME - Montenegro 1
MN - Mongolia 1
PS - Palestinian Territory 1
RO - Romania 1
TW - Taiwan 1
Totale 10.193
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.054
Chandler 752
Dublin 580
Singapore 516
Jacksonville 407
Abidjan 309
Chicago 307
Houston 291
Boardman 248
Catania 245
Cambridge 163
Lawrence 159
Andover 152
Nanjing 139
Toronto 115
Ashburn 113
Des Moines 96
Helsinki 94
Civitanova Marche 86
Nuremberg 79
Brussels 58
San Mateo 58
Dakar 57
Nanchang 56
Wilmington 49
Bremen 42
Council Bluffs 42
Hebei 36
Lappeenranta 35
Rome 35
Shenyang 35
Ottawa 31
Saint Petersburg 31
Jiaxing 29
Vienna 29
Dong Ket 28
Tianjin 27
Munich 25
Changsha 20
Brno 19
Falls Church 19
Pozzallo 19
Abuja 18
Los Angeles 18
Seattle 17
Shanghai 16
Beijing 15
São Paulo 14
Zhengzhou 14
Belo Horizonte 13
Norwalk 13
San Giovanni la Punta 13
Acireale 12
Grafing 12
Padova 12
L'Île-Saint-Denis 11
Rio de Janeiro 11
Messina 10
The Dalles 10
Washington 10
Mascalucia 9
Moscow 9
Naples 9
Redwood City 9
Porto Alegre 8
Salvador 8
Amsterdam 7
Den Haag 7
Guangzhou 7
Jinan 7
Lanzhou 7
Liberty Lake 7
Melbourne 7
Milan 7
Ningbo 7
Palermo 7
Redmond 7
Sydney 7
Taizhou 7
Turin 7
Bari 6
Bologna 6
Edinburgh 6
Manassas 6
Ragusa 6
Tokyo 6
Espinho 5
Hong Kong 5
Kunming 5
Maceió 5
Montreal 5
Sala Baganza 5
Tappahannock 5
Aci Catena 4
Adelaide 4
Arcadia 4
Baghdad 4
Berlin 4
Brasília 4
Campinas 4
Totale 7.173
Salva come PNG Salva come JPEG
Nome #
((2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist 207
Parallel Pair-Wise Interaction for Multi-Agent Immune Systems Modelling 192
iAtheroSim: atherosclerosis process simulator on smart devices. 110
2DIs: a SBML compliant web platform for the design and modeling of immune system interactions 105
Computational modeling of immunologic response to immune checkpoint inhibitors in COVID-19 patients with and without cancer 103
A MapReduce Based Tool for the Analysis and Discovery of Novel Therapeutic Targets 101
In silico clinical trials: concepts and early adoptions 100
Computational modelling in melanoma for novel drug discovery 95
R- ed S-LP2: sintesi, molecular docking e valutazione farmacologica 89
A multi-step and multi-scale bioinformatic protocol to investigate potential SARS-CoV-2 vaccine targets 88
A Credibility Assessment Plan for an In Silico Model that Predicts the Dose-Response Relationship of New Tuberculosis Treatments 87
Agent based modeling of the immune system: NetLogo, a promising framework 87
Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis 87
The Potential of Computational Modeling to Predict Disease Course and Treatment Response in Patients with Relapsing Multiple Sclerosis 85
Credibility of In Silico Trial Technologies - A Theoretical Framing 84
Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis 83
A biological optimization problem on the Grid 83
A MapReduce tool for in-depth analysis of KEGG pathways: identification and visualization of therapeutic target candidates 83
Combining agent based-models and virtual screening techniques to predict the best citrus-derived vaccine adjuvants against human papilloma virus 82
EpiMethEx: a tool for large-scale integrated analysis in methylation hotspots linked to genetic regulation 82
Gene Silencing of Transferrin-1 Receptor as a Potential Therapeutic Target for Human Follicular and Anaplastic Thyroid Cancer 81
Boosting multiple sclerosis lesion segmentation through attention mechanism 80
Toward computational modelling on immune system function 79
Evaluation of the efficacy of RUTI and ID93/GLA-SE vaccines in tuberculosis treatment: in silico trial through UISS-TB simulator 79
A novel paradigm for cell and molecule interaction ontology: from the CMM model to IMGT-ONTOLOGY 78
A genetic algorithm for shortest path motion problem in three dimensions 77
SimB16: modeling induced immune system response against B16-melanoma 77
An agent based modeling approach for the analysis of tuberculosis - Immune system dynamics 76
Computational modeling of the expansion of human cord blood CD133+ hematopoietic stem/progenitor cells with different cytokine combinations 76
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer 75
A computational model to predict the immune system activation by citrus derived vaccine adjuvants 74
Combining cellular automata and lattice Boltzmann method to model multiscale avascular tumor growth coupled with nutrient diffusion and immune competition 72
Abstract 5305: DNA methylation and gene expression in melanoma: A large-scale integrated analysis 72
Agent based simulations in disease modeling Comment on “Towards a unified approach in the modeling of fibrosis: A review with research perspectives” by Martine Ben Amar and Carlo Bianca 71
A methodological approach for using High-Level Petri Nets to model the immune system response 71
PEAK: A Clever Python Tool for Exploratory, Regression, and Classification Data. A Case Study for COVID-19 71
Modeling the competition between lung metastases and the immune system using agents 71
Agent based modeling of relapsing multiple sclerosis: A possible approach to predict treatment outcome 71
Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS) 71
Gene expression and pathway bioinformatics analysis detect a potential predictive value of MAP3K8 in thyroid cancer progression 71
Cancer immunoprevention: What can we learn from in silico models? 70
Advances in Computational Immunology 70
Optimization of HAART by means of Genetic Algorithms and agent based models of HIV infection 69
Modelling Vaccine Protocols 69
Computational modeling reveals MAP3K8 as mediator of resistance to vemurafenib in thyroid cancer stem cells 69
Computational modeling of brain pathologies: the case of multiple sclerosis 68
A modeling framework for immune-related diseases 68
Current issues in tumor immunology 67
Predictive models in tumor immunology 67
In silico design of recombinant multi-epitope vaccine against influenza A virus 67
Nose-to-Brain Drug Delivery and Physico-Chemical Properties of Nanosystems: Analysis and Correlation Studies of Data from Scientific Literature 66
Combining Parallel Genetic Algorithms and Machine Learning to Improve the Research of Optimal Vaccination Protocols 66
A model of cytotoxic T antitumor activation stimulated by pulsed dendritic cells 65
Moving forward through the in silico modeling of tuberculosis: a further step with UISS-TB 65
GPU accelerated analysis of treg-teff cross regulation in relapsing-remitting multiple sclerosis 64
Sexual risk behaviours 63
Induction of T cell memory by a dendritic cell vaccine: a computational model 62
Vaccine protocols optimization: in silico experiences 62
Translational immunomics of cancer immunoprevention 62
Computational models to predict disease course and treatment response in multiple sclerosis 62
Beyond the state of the art of reverse vaccinology: predicting vaccine efficacy with the universal immune system simulator for influenza 62
Searching of optimal vaccination schedules 61
Computational modelling approaches to vaccinology 61
Agent based modeling of lung metastasis-immune system competition 61
Analysis of vaccine's schedules using models, 61
Introducing scale factor adjustments on agent-based simulations of the immune system 61
Design and optimization of PEGylated nanoparticles intended for Berberine Chloride delivery 61
PETAL: A Python tool for deep analysis of biological pathways 61
Persistence analysis in a Kolmogorov-type model for cancer-immune system competition 60
Agent based modeling of humoral response to atherogenesis 60
BIOESOnet: A Tool for the Generation of Personalized Human Metabolic Pathways from 23andMe Exome Data 60
Mathematical and computational models in tumor immunology 60
SHyFTA, a Stochastic Hybrid Fault Tree Automaton for the modelling and simulation of Dynamic Reliability problem 59
Computational models as novel tools for cancer vaccines 59
In silico evaluation of daclizumab and vitamin D effects in multiple sclerosis using agent based models 59
Optimal vaccination schedules using Simulated Annealing 58
Computational simulations of the immune system for personalized medicine: state of the art and challenges 58
The dynamic-to-static conversion of Dynamic Fault Trees using Stochastic Dependency Graphs and Stochastic Activity Networks 58
Using Continuous Petri Nets to predict the impact of microRNA analysis in PI3K/Akt and MAPK Signaling Pathways 57
GRIDUISS - A grid based universal immune system simulator framework 57
Modelling Vaccination Schedules for a Cancer Immunoprevention Vaccine 57
Computational immunogenetics 57
Analysis of vaccine's schedules using models, 57
Reverse Vaccinology for Influenza A Virus: From Genome Sequencing to Vaccine Design 56
Compartmental mathematical modeling of immune system - melanoma competition 56
Cancer vaccines: state of the art of the computational modeling approaches 56
Generation of digital patients for the simulation of tuberculosis with UISS-TB 56
How can we accelerate COVID-19 vaccine discovery? 56
In silico trials: Verification, validation and uncertainty quantification of predictive models used in the regulatory evaluation of biomedical products 56
Mathematical modeling of biological systems 55
A hybrid model of the immune response against lung metastases 55
Modeling biology spanning different scales: An open challenge 55
A computational approach based on the colored Petri net formalism for studying multiple sclerosis 55
Universal Immune System Simulator framework (UISS) 54
Agent based modeling of atherosclerosis: a concrete help in personalized treatments 54
The combination of artificial intelligence and systems biology for intelligent vaccine design 54
A multi-step and multi-scale bioinformatic approach to investigate potential source of cross-reactive immunity against SARS-CoV-2 UK variant 53
Advancing PFAS risk assessment: Integrative approaches using agent-based modelling and physiologically-based kinetic for environmental and health safety 52
Optimal vaccination schedule search using genetic algorithm over MPI technology 52
Immune system modeling and related pathologies 52
Totale 7.139
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.480
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.480
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020132 0 0 0 0 0 0 0 0 0 0 89 43
2020/2021754 12 61 96 12 236 34 89 5 81 14 66 48
2021/20221.182 143 158 7 19 190 11 166 49 103 21 44 271
2022/20232.112 183 120 28 251 194 364 12 342 464 18 71 65
2023/20241.514 53 382 73 49 29 230 34 113 14 209 202 126
2024/20253.654 97 602 218 224 921 511 305 145 250 376 5 0
Totale 10.556